glp 1 drugs for pcos Ozempic (Semaglutide) PMOS/PCOS: Pelvic Health Guide GLP-1s and PMOS: PCOS, Insulin
Description
Patients with DT2 without obesity or excess weight with comorbidities can use liraglutide 1.8mg (daily, subcutaneous) and semaglutide 1mg (weekly, subcutaneous), or 14mg (daily, oral) for glycemic control
Overall, these findings raise concerns about GLP-1 RA use in patients with reduced LVEF
Boosting GIPR activity could directly affect the myocardium and indirectly influence cardiovascular function and outcomes through its systemic effects on other organs [13]
Exp Clin Endocrinol Diab
Although GLP-1Rs role is not fully understood or investigated in breast tissue when activated by different agonists, it may increase or decrease the progression of breast cancer [67, 68]
